A prominent clinical trial in South African called “Uhambo” was halted by the Data Safety Monitoring Review Board (DSMB) because the vaccine, HVTN 702, failed to prevent HIV transmission under 18 months into the study.   It is unfortunate as HIV/AIDs continues to be a...